Diagnostic News and Research

RSS
Daiichi Sankyo acquires Plexxikon

Daiichi Sankyo acquires Plexxikon

Vermillion, Quest Diagnostics enter agreement to launch OVA1 IVDMIA assay in India

Vermillion, Quest Diagnostics enter agreement to launch OVA1 IVDMIA assay in India

Quest Diagnostics completes Athena Diagnostics acquisition

Quest Diagnostics completes Athena Diagnostics acquisition

Oral cancer more common among Americans with HPV16 viral infections

Oral cancer more common among Americans with HPV16 viral infections

Study finds increased carbapenem use in VA acute care health facilities over the last 5 years

Study finds increased carbapenem use in VA acute care health facilities over the last 5 years

Study finds high utilization of CTC and Medicare coverage in recent years

Study finds high utilization of CTC and Medicare coverage in recent years

Life Technologies launches new TaqMan Mutation Detection Assays

Life Technologies launches new TaqMan Mutation Detection Assays

QIAGEN to acquire Cellestis

QIAGEN to acquire Cellestis

Transgenomic to present study results of high-sensitivity cancer mutation assays at AACR

Transgenomic to present study results of high-sensitivity cancer mutation assays at AACR

New research identifies diverse barriers to breast cancer screening and treatment

New research identifies diverse barriers to breast cancer screening and treatment

Recent releases in Global Health

Recent releases in Global Health

Elmhurst Memorial Healthcare chooses Merge Cardio, Merge Hemo for new facility

Elmhurst Memorial Healthcare chooses Merge Cardio, Merge Hemo for new facility

BC Psychological Association cautions against expanded gambling

BC Psychological Association cautions against expanded gambling

South Africa, Lesotho, Swaziland form alliance to fight MDR-TB

South Africa, Lesotho, Swaziland form alliance to fight MDR-TB

3M announces acquisition of Zargis Medical assets

3M announces acquisition of Zargis Medical assets

New Mexico Software annual revenue decreases 5% to $3.48 million

New Mexico Software annual revenue decreases 5% to $3.48 million

Scientists develop new experimental diagnostic test to distinguish infection from disease

Scientists develop new experimental diagnostic test to distinguish infection from disease

PGXL to utilize AutoGenomics' automated INFINITI analyzer for personalized medicine applications

PGXL to utilize AutoGenomics' automated INFINITI analyzer for personalized medicine applications

Analysis of non-tumor tissue may be an effective option for diagnosis of prostate cancer

Analysis of non-tumor tissue may be an effective option for diagnosis of prostate cancer

Oncology experts educate lawmakers about latest information on radiation therapy

Oncology experts educate lawmakers about latest information on radiation therapy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.